Nothing Special   »   [go: up one dir, main page]

CN114410477B - Inhibitor of inducible NO synthetase, and production strain and preparation method thereof - Google Patents

Inhibitor of inducible NO synthetase, and production strain and preparation method thereof Download PDF

Info

Publication number
CN114410477B
CN114410477B CN202111434433.4A CN202111434433A CN114410477B CN 114410477 B CN114410477 B CN 114410477B CN 202111434433 A CN202111434433 A CN 202111434433A CN 114410477 B CN114410477 B CN 114410477B
Authority
CN
China
Prior art keywords
rice
formula
culture medium
culture
inducible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202111434433.4A
Other languages
Chinese (zh)
Other versions
CN114410477A (en
Inventor
王立岩
李泓序
吴景婷
刘心怡
李晓帆
胡章立
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen University
Original Assignee
Shenzhen University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen University filed Critical Shenzhen University
Priority to CN202111434433.4A priority Critical patent/CN114410477B/en
Publication of CN114410477A publication Critical patent/CN114410477A/en
Application granted granted Critical
Publication of CN114410477B publication Critical patent/CN114410477B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P15/00Preparation of compounds containing at least three condensed carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses an inhibitor of inducible NO synthase, a production strain and a preparation method thereof; wherein, the deep sea fungus is preserved in China Center for Type Culture Collection (CCTCC) No. M20211395; the preservation time is as follows: 2021, 11/11. The deep sea fungi can effectively produce the compound with the inhibitory activity on Nitric Oxide (NO), and the compound not only has the efficacy of an inhibitor of inducible NO synthase (iNOS), but also has NO toxicity on cells, and can ensure that the cell survival rate reaches 100 percent without side effects.

Description

一种诱导型NO合成酶的抑制剂及其生产菌株和制备方法An inhibitor of inducible NO synthase and its production strain and preparation method

技术领域Technical field

本发明涉及生物制药领域,具体涉及一种诱导型NO合成酶的抑制剂及其生产菌株和制备方法。The invention relates to the field of biopharmaceuticals, and specifically relates to an inhibitor of inducible NO synthase, its production strain and preparation method.

背景技术Background technique

炎症是由外来病原体和有害刺激物的入侵激活的重要生理细胞反应,被认为是一种先天免疫机制,有助于修复受损组织并清除刺激物和受损细胞。作为一种潜在的自卫机制,炎症是一个复杂的生理过程,涉及免疫/血管系统和分子介质,所有这些都参与隔离炎症因子,如细菌、病毒和受损细胞。活化的巨噬细胞通过分泌多种促炎介质来介导炎症过程,包括一氧化氮(NO)、前列腺素E2(PGE2)、肿瘤坏死因子-α(TNF-α)、白介素-1β(IL-1β)和白介素-6(IL-6)。其中NO是一种细胞来源的信号分子,由诱导型一氧化氮合酶(iNOS)产生,这种重要的生理分子表现出多种生物功能,例如血管舒张,通过放松和减少平滑肌细胞和血小板聚集将白细胞募集到组织中。然而,NO的异常产生会导致超氧阴离子(ONOO-)的形成、DNA损伤和细胞死亡。Inflammation is an important physiological cellular response activated by the invasion of foreign pathogens and harmful irritants and is considered an innate immune mechanism that helps repair damaged tissues and clear irritants and damaged cells. As a potential self-defense mechanism, inflammation is a complex physiological process involving the immune/vasculature system and molecular mediators, all of which are involved in sequestering inflammatory agents such as bacteria, viruses, and damaged cells. Activated macrophages mediate the inflammatory process by secreting a variety of pro-inflammatory mediators, including nitric oxide (NO), prostaglandin E2 (PGE2), tumor necrosis factor-α (TNF-α), interleukin-1β (IL- 1β) and interleukin-6 (IL-6). NO is a cell-derived signaling molecule produced by inducible nitric oxide synthase (iNOS). This important physiological molecule exhibits a variety of biological functions, such as vasodilation, by relaxing and reducing smooth muscle cells and platelet aggregation. Recruits white blood cells into tissues. However, abnormal production of NO can lead to the formation of superoxide anion (ONOO-), DNA damage, and cell death.

有关各种炎症致病作用的机理,已知体内一氧化氮(NO)是介导细胞免疫和炎症的毒性物质。其前体是左旋精氨酸(L-arg),L-arg在NO合成酶(NOS)的作用下生成NO。目前已经分离出三种不同类型的NOS,包括内皮NO合成酶(eNOS),神经元NO合成酶(nNOS)及诱导型NO合成酶(iNOS)。目前已知,巨噬细胞、肝细胞、平滑肌细胞、腺癌细胞以及上皮细胞均能表达iNOS。某些炎性细胞因子和微生物产物如脂多糖(LPS)则可诱导iNOS表达。iNOS一旦被诱导即可表达出高度活性,产生大量NO。NO的过量生成造成炎症的增恶,甚至最终引发癌症。Regarding the mechanism of various inflammatory pathogenic effects, it is known that nitric oxide (NO) in the body is a toxic substance that mediates cellular immunity and inflammation. Its precursor is L-arginine (L-arg), which generates NO under the action of NO synthase (NOS). Three different types of NOS have been isolated so far, including endothelial NO synthase (eNOS), neuronal NO synthase (nNOS) and inducible NO synthase (iNOS). It is currently known that macrophages, hepatocytes, smooth muscle cells, adenocarcinoma cells and epithelial cells can all express iNOS. Certain inflammatory cytokines and microbial products such as lipopolysaccharide (LPS) can induce iNOS expression. Once induced, iNOS can express high activity and produce large amounts of NO. Excessive production of NO causes inflammation and even eventually causes cancer.

因此,长时间以来,人们致力于寻找诱导型NO合成酶iNOS的抑制剂来治疗与之相关的炎性疾病。但这些抑制剂大多局限于化学合成的物质,副作用较大。Therefore, for a long time, people have been committed to finding inhibitors of inducible NO synthase iNOS to treat inflammatory diseases related to it. However, most of these inhibitors are limited to chemically synthesized substances and have serious side effects.

发明内容Contents of the invention

因此,本发明要解决的技术问题在于克服现有技术中的诱导型NO合成酶iNOS的抑制剂均是采用化学合成,导致副作用较大的缺陷,从而提供对细胞无伤害的一种诱导型NO合成酶的抑制剂及其生产菌株和制备方法。Therefore, the technical problem to be solved by the present invention is to overcome the shortcoming of existing inhibitors of inducible NO synthase iNOS that are chemically synthesized, resulting in greater side effects, thereby providing an inducible NO that does no harm to cells. Synthase inhibitors, production strains and preparation methods thereof.

一种深海真菌(Trichoderma sp.SCSIOW21),该深海真菌Trichodermasp.SCSIOW21保藏于中国典型培养物保藏中心,地址为中国.武汉.武汉大学,保藏编号为CCTCC No:M20211395,保藏时间为2021年11月11日。A deep-sea fungus (Trichoderma sp.SCSIOW21). The deep-sea fungus Trichoderma sp.SCSIOW21 is deposited in the China Type Culture Collection Center. The address is Wuhan University, China. The deposit number is CCTCC No: M20211395. The deposit date is November 2021. 11th.

一种利用上述的深海真菌生产诱导型NO合成酶的抑制剂的应用。An application of utilizing the above-mentioned deep-sea fungus to produce an inhibitor of inducible NO synthase.

一种诱导型NO合成酶的抑制剂,包括以下式1-式7中至少一种化合物,An inhibitor of inducible NO synthase, including at least one compound of the following formula 1 to formula 7,

一种诱导型NO合成酶的抑制剂的制备方法,包括:将上述的深海真菌进行培养获得培养物,从培养物中分离获得包含式1-式7中至少一种化合物的产物。A method for preparing an inhibitor of inducible NO synthase, including: culturing the above-mentioned deep-sea fungus to obtain a culture, and isolating from the culture a product containing at least one compound of Formula 1 to Formula 7.

所述培养过程为:深海真菌菌种复苏后,将菌种接种到种子培养基中,在27~29℃培养47~49小时,得到种子培养液;再将种子培养液接种到大米培养基中,培养40~50天,获得培养物。The culture process is as follows: after the deep-sea fungal strains are revived, the strains are inoculated into the seed culture medium, and cultured at 27-29°C for 47-49 hours to obtain the seed culture liquid; then the seed culture liquid is inoculated into the rice culture medium. , culture for 40 to 50 days, and obtain the culture.

所述种子培养基以质量百分数计,包括:葡萄糖1.9~2.1%,蛋白胨0.9~1.1%,酵母提取物0.4~0.6%,海盐2~4%,余量为水。In terms of mass percentage, the seed culture medium includes: glucose 1.9-2.1%, peptone 0.9-1.1%, yeast extract 0.4-0.6%, sea salt 2-4%, and the balance is water.

所述大米培养基包括海盐、水和大米;所述海盐:水:大米的质量比为7~8:240~260:140~160。The rice culture medium includes sea salt, water and rice; the mass ratio of sea salt:water:rice is 7-8:240-260:140-160.

所述大米培养基的制备方法为:按比例称取海盐溶于去离子水中,待海盐完全溶解后,加入大米,浸泡过夜。The preparation method of the rice culture medium is as follows: weigh the sea salt in proportion and dissolve it in deionized water. After the sea salt is completely dissolved, add the rice and soak it overnight.

大米培养基中深海真菌的接种量为:每140~160g大米中接种5mL种子培养液。The inoculum amount of deep-sea fungi in the rice culture medium is: inoculate 5 mL of seed culture solution per 140 to 160 g of rice.

所述分离的过程为:将培养物依次用乙酸乙酯、正丁醇进行液液萃取,收集正丁醇萃取液,正丁醇萃取液浓缩得发酵液浸膏;重复前述萃取步骤至少一次,合并发酵液浸膏得正丁醇级分;正丁醇级分采用硅胶柱层析获取极性大小不同的A-H八个组分,从B-D组分中通过反向硅胶柱层析、反向HPLC分离纯化得到式1-式7中的任意一种或多种化合物。The separation process is: sequentially perform liquid-liquid extraction of the culture with ethyl acetate and n-butanol, collect the n-butanol extract, and concentrate the n-butanol extract to obtain fermentation liquid extract; repeat the aforementioned extraction steps at least once, The n-butanol fraction is obtained by combining the fermentation broth extract; the n-butanol fraction is subjected to silica gel column chromatography to obtain eight components A-H with different polarities, and the B-D components are passed through reverse silica gel column chromatography and reverse HPLC. Any one or more compounds of Formula 1 to Formula 7 can be obtained by isolation and purification.

将B和C组分合并,然后通过中压ODS色谱柱使用MeOH-水进行梯度洗脱得到5个亚级分,分别命名为子馏分1-5。对子馏分2纯化分离得到式1所示的化合物;对子馏分3纯化分离得到式2、式7、式6所示的化合物;对子馏分5纯化分离得到式3所示的化合物。Components B and C were combined, and then passed through a medium-pressure ODS chromatography column using MeOH-water for gradient elution to obtain 5 subfractions, which were named subfractions 1-5. Purify and isolate sub-fraction 2 to obtain the compound represented by formula 1; purify and isolate sub-fraction 3 to obtain compounds represented by formula 2, formula 7 and formula 6; purify and isolate sub-fraction 5 to obtain the compound represented by formula 3.

将D组分进行中压液相色谱YMC-ODS-A C18色谱柱的分离,使用MeOH-水进行梯度洗脱得到14个亚级分,分别命名为亚级分1-14,其中亚级分7纯化分离得到式5所示的化合物,亚级分9纯化分离得到式4所示的化合物。The D component was separated on a medium-pressure liquid chromatography YMC-ODS-A C 18 column, using MeOH-water for gradient elution to obtain 14 subfractions, which were named subfractions 1-14, among which the subfractions The compound represented by formula 5 is purified and separated in sub-fraction 7, and the compound represented by formula 4 is purified and separated in sub-fraction 9.

本发明技术方案,具有如下优点:The technical solution of the present invention has the following advantages:

1.本发明提供的深海真菌,其能够有效生产出对一氧化氮(NO)产生抑制活性的化合物,该化合物不仅仅具有诱导型NO合成酶iNOS的抑制剂的功效,并且对细胞无毒性,可以保证细胞存活率达到100%,无副作用。1. The deep-sea fungus provided by the present invention can effectively produce a compound that inhibits nitric oxide (NO). The compound not only has the effect of an inhibitor of inducible NO synthase iNOS, but is also non-toxic to cells. It can ensure that the cell survival rate reaches 100% without side effects.

2.本发明提供的式1-式7中的化合物经过检测得出,均对一氧化氮(NO)产生抑制活性,因此可以作为诱导型NO合成酶的抑制剂使用;其中,在实验浓度为100μM时,式2和式7两个化合物的抑制率可以分别达到81.8%和50.5%,且对应的细胞存活率均是100%,表明式2和式7的两个化合物在这种浓度下均具有较好的NO抑制活性,并且对细胞无毒性,该化合物可用于制备抑制一氧化氮产生的药物,即可以作为诱导型NO合成酶的抑制剂使用。2. The compounds in formulas 1 to 7 provided by the present invention have been tested and found to have inhibitory activity on nitric oxide (NO), and therefore can be used as inhibitors of inducible NO synthase; wherein, at the experimental concentration: At 100 μM, the inhibition rates of the two compounds of Formula 2 and Formula 7 can reach 81.8% and 50.5% respectively, and the corresponding cell survival rates are both 100%, indicating that the two compounds of Formula 2 and Formula 7 are effective at this concentration. It has good NO inhibitory activity and is non-toxic to cells. The compound can be used to prepare drugs that inhibit the production of nitric oxide, that is, it can be used as an inhibitor of inducible NO synthase.

附图说明Description of the drawings

为了更清楚地说明本发明具体实施方式或现有技术中的技术方案,下面将对具体实施方式或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图是本发明的一些实施方式,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly explain the specific embodiments of the present invention or the technical solutions in the prior art, the accompanying drawings that need to be used in the description of the specific embodiments or the prior art will be briefly introduced below. Obviously, the drawings in the following description The drawings illustrate some embodiments of the present invention. For those of ordinary skill in the art, other drawings can be obtained based on these drawings without exerting any creative effort.

图1是本发明实施例1中式1和式2进行X光单晶衍射得到的绝对构型图;Figure 1 is an absolute configuration diagram obtained by X-ray single crystal diffraction of Formula 1 and Formula 2 in Example 1 of the present invention;

图2是本发明中是对化合物进行ECD计算获得的光谱曲线图。Figure 2 is a spectral curve obtained by performing ECD calculation on the compound in the present invention.

图3是本发明中式1-式7的化合物对RAW264.7细胞一氧化氮(NO)抑制效果图。Figure 3 is a diagram showing the inhibitory effect of compounds of Formula 1 to Formula 7 of the present invention on nitric oxide (NO) in RAW264.7 cells.

具体实施方式Detailed ways

实施例1Example 1

一种深海真菌(Trichoderma sp.SCSIOW21),该深海真菌Trichodermasp.SCSIOW21保藏于中国典型培养物保藏中心,地址为中国.武汉.武汉大学,保藏编号为CCTCC No:M20211395,保藏时间为2021年11月11日。A deep-sea fungus (Trichoderma sp.SCSIOW21). The deep-sea fungus Trichoderma sp.SCSIOW21 is deposited in the China Type Culture Collection Center. The address is Wuhan University, China. The deposit number is CCTCC No: M20211395. The deposit date is November 2021. 11th.

利用上述深海真菌Trichoderma sp.SCSIOW21进行发酵培育并分离出诱导型NO合成酶的抑制剂的过程为:The process of using the above-mentioned deep-sea fungus Trichoderma sp.SCSIOW21 to carry out fermentation cultivation and isolating the inhibitor of inducible NO synthase is as follows:

一、种子培养:1. Seed cultivation:

将低温保藏的深海真菌菌种Trichoderma sp.SCSIOW21复苏后,将菌种接种到种子培养基中,于28℃、200r/min转速下摇床培养47~49小时得到种子培养液。其中,种子培养基的配方为:葡萄糖2%,蛋白胨1%,酵母提取物0.5%,海盐3%,其余为水;经121℃高压灭菌20分钟。After reviving the cryopreserved deep-sea fungal strain Trichoderma sp.SCSIOW21, the strain was inoculated into the seed culture medium and cultured on a shaking table at 28°C and 200 r/min for 47 to 49 hours to obtain a seed culture medium. Among them, the formula of the seed culture medium is: 2% glucose, 1% peptone, 0.5% yeast extract, 3% sea salt, and the rest is water; it is autoclaved at 121°C for 20 minutes.

二、发酵培养:2. Fermentation and culture:

在超净的工作台中,将5mL种子培养液接入装有大米培养基的2000mL的锥形瓶中,总共60瓶。室温静置培养40天,获得深海真菌Trichoderma sp.SCSIOW21的发酵培养物。In an ultra-clean workbench, add 5 mL of seed culture solution into a 2000 mL Erlenmeyer flask containing rice culture medium, a total of 60 bottles. After static cultivation at room temperature for 40 days, a fermentation culture of the deep-sea fungus Trichoderma sp.SCSIOW21 was obtained.

其中,大米培养基的配置过程为:称取450克海盐溶于15升的去离子水中,待海盐完全溶解后,平均分装于60个装有150克大米的2000mL的锥形瓶中,浸泡过夜。Among them, the preparation process of rice culture medium is: weigh 450 grams of sea salt and dissolve it in 15 liters of deionized water. After the sea salt is completely dissolved, evenly distribute it into 60 2000mL Erlenmeyer flasks containing 150 grams of rice, and soak overnight.

三、提取分离:3. Extraction and separation:

培养结束时,在每个锥形瓶中加入100mL乙酸乙酯(EtOAc),在低于50℃下的真空旋转蒸发器中浓缩,蒸发剩余的EtOAc后,在每个锥形瓶中加入100mL水饱和的正丁醇(BuOH)并在真空旋转蒸发器下浓缩3次得到BuOH级分(12.9g)。At the end of the culture, add 100 mL of ethyl acetate (EtOAc) to each Erlenmeyer flask and concentrate in a vacuum rotary evaporator below 50°C. After evaporating the remaining EtOAc, add 100 mL of water to each Erlenmeyer flask. Saturated n-butanol (BuOH) and concentrated 3 times on a vacuum rotary evaporator to give a BuOH fraction (12.9 g).

将BuOH级分拌入硅胶后装硅胶柱,以氯仿(CH2Cl2)-甲醇(MeOH)-水为洗脱溶剂进行洗脱,依次采用100%CH2Cl2,体积比为50:1:0、20:1:0、10:1:0、5:1:0.1、3:1:0.1、1:1:0.1的CH2Cl2-MeOH-水,和100%的MeOH各2.0L进行洗脱,得到A-H八个组分。Stir the BuOH fraction into silica gel and install it into a silica gel column. Use chloroform (CH 2 Cl 2 )-methanol (MeOH)-water as the elution solvent for elution. Use 100% CH 2 Cl 2 in sequence, with a volume ratio of 50:1. :0, 20:1:0, 10:1:0, 5:1:0.1, 3:1:0.1, 1:1:0.1 CH 2 Cl 2 -MeOH-water, and 2.0L each of 100% MeOH Perform elution to obtain eight components of AH.

将组分B和组分C合并,并通过常压下C18色谱柱洗脱,依次使用体积比为5:5、6:4、7:3、8:2、9:1、10:0的MeOH-水各1000mL进行洗脱,常压下自然流速得到6个组分,分别命名为子馏分1-6。通过半制备型YMC-ODS-A C18(20×250mm,5μm)HPLC柱(乙腈-水体积比40:60,5.0ml/min,tR 52.1min)分离第2号组分,得到式1(9.0mg)。通过半制备型YMC-ODS-A C18(20×250mm,5μm)HPLC柱(乙腈-水体积比47:53,10ml/min)纯化第3号组分,得到式2(tR49.2min,3.0mg)、式7(tR32.8min,0.3mg)和式6(tR 34.1min,0.4mg)。通过半制备型YMC-ODS-AC18(20×250mm,5μm)HPLC柱(乙腈-水体积比为70:30,10.0ml/min,tR15.9min)分离第5号组分,得到式3(0.5mg)。Combine component B and component C and elute through a C 18 chromatographic column under normal pressure, using a volume ratio of 5:5, 6:4, 7:3, 8:2, 9:1, and 10:0. Elute with 1000 mL of MeOH-water each, and obtain 6 components at natural flow rate under normal pressure, which are named subfractions 1-6 respectively. Separate the No. 2 component through a semi-preparative YMC-ODS-A C 18 (20×250mm, 5μm) HPLC column (acetonitrile-water volume ratio 40:60, 5.0ml/min, t R 52.1min) to obtain formula 1 (9.0mg). Component No. 3 was purified through a semi-preparative YMC-ODS-A C 18 (20×250mm, 5μm) HPLC column (acetonitrile-water volume ratio 47:53, 10ml/min) to obtain formula 2 (t R 49.2min, 3.0mg), Formula 7 (t R 32.8min, 0.3mg) and Formula 6 (t R 34.1min, 0.4mg). Separate component No. 5 through a semi-preparative YMC-ODS-AC 18 (20×250mm, 5μm) HPLC column (acetonitrile-water volume ratio 70:30, 10.0ml/min, t R 15.9min) to obtain formula 3 (0.5mg).

将组分D通过常压下YMC-ODS-A C18色谱柱洗脱,梯度为MeOH-水(1:9、2:8、3:7、4:6、5:5、6:4、7:3、8:2、9:1和100%MeOH)各1000mL洗脱,得到10个组分,分别命名为亚级分1-10。通过半制备型YMC-ODS-A C18(20×250mm,5μm)HPLC柱(乙腈-水体积比18:82,10ml/min,tR 29.6min)纯化第7个组分,得到式5(1.6mg)。通过半制备型YMC-ODS-A C18(20×250mm,5μm)HPLC柱(乙腈-水体积比23:77,10.0ml/min,tR 41.5min)纯化组分9,得到式4(0.6mg)。Component D was eluted through YMC-ODS-A C 18 chromatographic column under normal pressure, with a gradient of MeOH-water (1:9, 2:8, 3:7, 4:6, 5:5, 6:4, 7:3, 8:2, 9:1 and 100% MeOH) were eluted with 1000 mL each, and 10 components were obtained, which were named subfractions 1-10. The seventh component was purified through a semi-preparative YMC-ODS-A C 18 (20×250mm, 5μm) HPLC column (acetonitrile-water volume ratio 18:82, 10ml/min, t R 29.6min) to obtain formula 5 ( 1.6 mg). Component 9 was purified through a semi-preparative YMC-ODS-A C 18 (20×250mm, 5μm) HPLC column (acetonitrile-water volume ratio 23:77, 10.0ml/min, t R 41.5min) to obtain formula 4 (0.6 mg).

实施例2Example 2

利用上述深海真菌Trichoderma sp.SCSIOW21进行发酵培育并分离出诱导型NO合成酶的抑制剂的过程为:The process of using the above-mentioned deep-sea fungus Trichoderma sp.SCSIOW21 to carry out fermentation cultivation and isolating the inhibitor of inducible NO synthase is as follows:

一、种子培养:1. Seed cultivation:

将低温保藏的深海真菌菌种Trichoderma sp.SCSIOW21复苏后,将菌种接种到种子培养基中,于27℃、200r/min转速下摇床培养47~49小时得到种子培养液。其中,以质量百分数计,种子培养基的配方为:葡萄糖1.9%,蛋白胨1.1%,酵母提取物0.6%,海盐4%,其余为水;经121℃高压灭菌20分钟。After reviving the cryopreserved deep-sea fungal strain Trichoderma sp. SCSIOW21, the strain was inoculated into the seed culture medium and cultured on a shaking table at 27°C and 200 r/min for 47 to 49 hours to obtain a seed culture medium. Among them, in terms of mass percentage, the formula of the seed culture medium is: 1.9% glucose, 1.1% peptone, 0.6% yeast extract, 4% sea salt, and the rest is water; it is autoclaved at 121°C for 20 minutes.

二、发酵培养:2. Fermentation and culture:

在超净的工作台中,将5mL种子培养液接入装有大米培养基的2000mL的锥形瓶中,总共60瓶。室温静置培养40天,获得深海真菌Trichoderma sp.SCSIOW21的发酵培养物。In an ultra-clean workbench, add 5 mL of seed culture solution into a 2000 mL Erlenmeyer flask containing rice culture medium, a total of 60 bottles. After static cultivation at room temperature for 40 days, a fermentation culture of the deep-sea fungus Trichoderma sp.SCSIOW21 was obtained.

其中,大米培养基的配置过程为:称取420克海盐溶于15.6升的去离子水中,待海盐完全溶解后,平均分装于60个装有140克大米的2000mL的锥形瓶中,浸泡过夜。Among them, the preparation process of the rice culture medium is as follows: weigh 420 grams of sea salt and dissolve it in 15.6 liters of deionized water. After the sea salt is completely dissolved, distribute it evenly into 60 2000mL Erlenmeyer flasks containing 140 grams of rice, and soak overnight.

三、提取分离:提取分离过程与实施例1相同。3. Extraction and separation: The extraction and separation process is the same as in Example 1.

实施例3Example 3

利用上述深海真菌Trichoderma sp.SCSIOW21进行发酵培育并分离出诱导型NO合成酶的抑制剂的过程为:The process of using the above-mentioned deep-sea fungus Trichoderma sp.SCSIOW21 to carry out fermentation cultivation and isolating the inhibitor of inducible NO synthase is as follows:

一、种子培养:1. Seed cultivation:

将低温保藏的深海真菌菌种Trichoderma sp.SCSIOW21复苏后,将菌种接种到种子培养基中,于29℃、200r/min转速下摇床培养47~49小时得到种子培养液。其中,种子培养基的配方为:葡萄糖2.1%,蛋白胨0.9%,酵母提取物0.4%,海盐2%,其余为水;经121℃高压灭菌20分钟。After reviving the cryopreserved deep-sea fungal strain Trichoderma sp. SCSIOW21, the strain was inoculated into the seed culture medium, and cultured on a shaking table at 29°C and 200 r/min for 47 to 49 hours to obtain a seed culture medium. Among them, the formula of the seed culture medium is: glucose 2.1%, peptone 0.9%, yeast extract 0.4%, sea salt 2%, and the rest is water; it is autoclaved at 121°C for 20 minutes.

二、发酵培养:2. Fermentation and culture:

在超净的工作台中,将5mL种子培养液接入装有大米培养基的2000mL的锥形瓶中,总共60瓶。室温静置培养40天,获得深海真菌Trichoderma sp.SCSIOW21的发酵培养物。In an ultra-clean workbench, add 5 mL of seed culture solution into a 2000 mL Erlenmeyer flask containing rice culture medium, a total of 60 bottles. After static cultivation at room temperature for 40 days, a fermentation culture of the deep-sea fungus Trichoderma sp.SCSIOW21 was obtained.

其中,大米培养基的配置过程为:称取480克海盐溶于14.4升的去离子水中,待海盐完全溶解后,平均分装于60个装有160克大米的2000mL的锥形瓶中,浸泡过夜。Among them, the preparation process of the rice culture medium is as follows: weigh 480 grams of sea salt and dissolve it in 14.4 liters of deionized water. After the sea salt is completely dissolved, distribute it evenly into 60 2000mL Erlenmeyer flasks containing 160 grams of rice, and soak overnight.

三、提取分离:提取分离过程与实施例1相同。3. Extraction and separation: The extraction and separation process is the same as in Example 1.

试验例1:式1-7的化合物相对结构鉴定Test Example 1: Relative structural identification of compounds of formulas 1-7

上述实施例1中制备得到的式1-7的化合物进行结构分析测试,得到以下理化性质数据。The compounds of Formulas 1-7 prepared in the above Example 1 were subjected to structural analysis and testing, and the following physical and chemical property data were obtained.

式1:无色晶体;[α]25 D+64.1(c 0.36,MeOH);UV(MeOH)λmax(logε)252.6(3.77)nm;ECD(0.12mg/ml,MeOH)λmax(Δε)245(-36.7),292(+7.4),351(+10.6)nm;IR(KBr)vmax 3402,2927,1734,1695,1541,1435,1338,1190,1043cm-1;NMR数据(600/150MHz,DMSO-d6,TMS为内标,J in Hz,δin ppm)见表1;HREIMS m/z:317.2115[M+H]+(计算得C20H29O3,317.2117)。Formula 1: Colorless crystal; [α] 25 D +64.1(c 0.36,MeOH); UV(MeOH)λ max (logε)252.6(3.77)nm; ECD(0.12mg/ml,MeOH)λ max (Δε) 245(-36.7),292(+7.4),351(+10.6)nm; IR(KBr)v max 3402,2927,1734,1695,1541,1435,1338,1190,1043cm-1; NMR data (600/ 150MHz, DMSO-d 6 , TMS is the internal standard, J in Hz, δin ppm) are shown in Table 1; HREIMS m/z: 317.2115[M+H] + (calculated as C 20 H 29 O 3 ,317.2117).

表1Table 1

式4:无色胶状;[α]25 D+15.3(c 0.28,MeOH);UV(MeOH)λmax(logε)256.0(3.89)nm;ECD(0.14mg/ml,MeOH)λmax(Δε)247(-36.7),349(+2.7)nm;IR(KBr)vmax 3402,2927,1734,1695,1541,1435,1338,1190,1043cm-1;NMR数据(600/150MHz,DMSO-d6,TMS为内标,J inHz,δin ppm)见表2;HREIMS m/z:319.2278[M+H]+(计算得C20H31O3,319.2273)。Formula 4: colorless gel; [α] 25 D +15.3 (c 0.28, MeOH); UV (MeOH) λ max (logε) 256.0 (3.89) nm; ECD (0.14 mg/ml, MeOH) λ max (Δε )247(-36.7),349(+2.7)nm; IR(KBr)v max 3402,2927,1734,1695,1541,1435,1338,1190,1043cm -1 ; NMR data (600/150MHz, DMSO-d 6 , TMS is the internal standard, J inHz, δin ppm) see Table 2; HREIMS m/z: 319.2278[M+H]+ (calculated C 20 H 31 O 3 ,319.2273).

表2Table 2

a重叠信号。 a Overlapping signals.

式5:无色胶状;[α]25 D+14.1(c 0.15,MeOH);UV(MeOH)λmax(logε)251.0(4.07)nm;ECD(0.15mg/ml,MeOH)λmax(Δε)245(-8.2),358(+4.8)nm;IR(KBr)vmax 3360,2922,1732,1668,1541,1435,1338,1122,1024cm-1;1H NMR和13C NMR数据(600/150MHz,DMSO-d6,TMS为内标,Jin Hz,δin ppm)见表3;HREIMS m/z:335.2229[M+H]+(计算得C20H31O4,335.2222)。Formula 5: Colorless gel; [α] 25 D +14.1(c 0.15,MeOH); UV(MeOH)λ max (logε)251.0(4.07)nm; ECD(0.15mg/ml,MeOH)λ max (Δε )245(-8.2),358(+4.8)nm; IR(KBr)v max 3360,2922,1732,1668,1541,1435,1338,1122,1024cm-1; 1 H NMR and 13 C NMR data (600 /150MHz, DMSO-d 6 , TMS is the internal standard, Jin Hz, δin ppm) are shown in Table 3; HREIMS m/z: 335.2229[M+H] + (calculated C 20 H 31 O 4 ,335.2222).

表3table 3

式6:无定形粉末;[α]25 D+10.1(c 0.18,MeOH);UV(MeOH)λmax(l ogε)252.3(4.19)nm;ECD(0.18mg/ml,MeOH)λmax(Δε)220(+1.7),245(-4.9),353(+2.4)nm;IR(KBr):vmax3379,2924,1734,1647,1558,1456,1435,1153,1049cm-1;1H NMR和13C NMR数据(600/150MHz,DMSO-d6,TMS为内标,J in Hz,δin ppm)见表4;HREIMS m/z:341.2089[M+Na]+(计算得C20H30NaO3,341.2093)。Formula 6: Amorphous powder; [α] 25 D +10.1(c 0.18,MeOH); UV(MeOH)λ max (logε)252.3(4.19)nm; ECD(0.18mg/ml,MeOH)λ max (Δε 1 H NMR and 13 C NMR data (600/150MHz, DMSO-d 6 , TMS as internal standard, J in Hz, δin ppm) are shown in Table 4; HREIMS m/z: 341.2089[M+Na] + (calculated C 20 H 30 NaO 3 ,341.2093).

表4Table 4

式7:无定形粉末;[α]25 D+12.0(c 0.14,MeOH);UV(MeOH)λmax(logε)256.3(4.11)nm;ECD(0.14mg/ml,MeOH)λmax(Δε)255(-1.8),340(+1.1)nm;IR(KBr)vmax3360,2922,1718,1660,1558,1465,1338,1147,1058cm-1;1H NMR和13C NMR数据(600/150MHz,DMSO-d6,TMS为内标,Jin Hz,δin ppm)见表5;HREIMS m/z:319.2269[M+H]+(计算得C20H31O3,319.2273)。Formula 7: Amorphous powder; [α] 25 D +12.0(c 0.14,MeOH); UV(MeOH)λ max (logε)256.3(4.11)nm; ECD(0.14mg/ml,MeOH)λ max (Δε) 255(-1.8),340(+1.1)nm; IR(KBr)v max 3360,2922,1718,1660,1558,1465,1338,1147,1058cm-1; 1H NMR and 13C NMR data (600/ 150MHz, DMSO-d 6 , TMS is the internal standard, Jin Hz, δin ppm) are shown in Table 5; HREIMS m/z: 319.2269[M+H] + (calculated C 20 H 31 O 3 ,319.2273).

表5table 5

对式1和式2进行X光单晶衍射,得到其绝对构型,如图1所示,其中a为式1的绝对构型图,b为式2的绝对构型图。将得到的其他化合物进行ECD计算确定其绝对构型,实验结果如图2所示,其中,A为实验和计算曲线(2S,5R,6R,8S,13S,14S)ECD式1光谱,B为实验和计算曲线(2S,5R,6R,13S,14S)ECD式4光谱,C为实验和计算曲线(2S,5R,6R,8S,13S,14S)ECD式5光谱,D为实验和计算曲线(2S,5R,6R,8S,13S,14S)ECD式6光谱,E为实验和计算曲线(2S,5R,6R,13S,14S,15S)ECD式7光谱。X-ray single crystal diffraction was performed on Formula 1 and Formula 2 to obtain their absolute configuration, as shown in Figure 1, where a is the absolute configuration diagram of Formula 1 and b is the absolute configuration diagram of Formula 2. The other compounds obtained were subjected to ECD calculation to determine their absolute configuration. The experimental results are shown in Figure 2, where A is the experimental and calculated curve (2S, 5R, 6R, 8S, 13S, 14S) ECD formula 1 spectrum, and B is Experimental and calculated curves (2S, 5R, 6R, 13S, 14S) ECD formula 4 spectrum, C is the experimental and calculated curve (2S, 5R, 6R, 8S, 13S, 14S) ECD formula 5 spectrum, D is the experimental and calculated curve (2S, 5R, 6R, 8S, 13S, 14S) ECD formula 6 spectrum, E is the experimental and calculated curve (2S, 5R, 6R, 13S, 14S, 15S) ECD formula 7 spectrum.

根据以上表1-表5理化数据分析,并结合式1-式7的绝对构型的ECD试验计算结果,可以确定式1-式7的绝对结构如下所示:Based on the above analysis of the physical and chemical data in Tables 1 to 5, combined with the ECD test calculation results of the absolute configurations of Formula 1 to Formula 7, it can be determined that the absolute structures of Formula 1 to Formula 7 are as follows:

由此,可以证明本发明的深海真菌Trichoderma sp.SCSIOW21可以有效生产并分离出式1-式7所示的化合物。Therefore, it can be proved that the deep-sea fungus Trichoderma sp. SCSIOW21 of the present invention can effectively produce and isolate the compounds represented by Formula 1 to Formula 7.

试验例2:式1-式7所示化合物的抗炎活性的实验Test Example 2: Experiment on the anti-inflammatory activity of compounds represented by Formula 1 to Formula 7

1、检测细胞培养1. Detection of cell culture

购自美国典型培养物保藏中心(ATCC,Manassas,VA,USA)的小鼠RAW264.7巨噬细胞在提供10%热灭活胎牛血清(Gibco)的RPMI-1640培养基中在37℃下,5%CO2和95%空气的加湿培养箱培养。每两天定期更换培养基。RAW264.7细胞达到融合后通过胰蛋白酶消化传代获得检测细胞。Mouse RAW264.7 macrophages were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA) in RPMI-1640 medium supplied with 10% heat-inactivated fetal calf serum (Gibco) at 37°C. , culture in a humidified incubator with 5% CO2 and 95% air. The culture medium was changed regularly every two days. After RAW264.7 cells reached confluence, they were digested with trypsin and passaged to obtain detection cells.

2、一氧化氮抑制试验2. Nitric oxide inhibition test

将检测细胞以1.0×105个细胞/孔的密度接种在96孔板中并生长2小时,使细胞附着在板上。将测试样品溶解在DMSO(二甲基亚砜)中,然后在RPMI-1640(Thermo FisherScientific,Carlsbad,CA,USA)培养基中进行两倍浓度梯度稀释,使培养基中样品式1–式7的最终浓度为100、50、和25μM。The detection cells were seeded in a 96-well plate at a density of 1.0 × 10 5 cells/well and grown for 2 hours to allow the cells to adhere to the plate. Dissolve the test sample in DMSO (dimethyl sulfoxide), and then perform a two-fold concentration gradient dilution in RPMI-1640 (Thermo Fisher Scientific, Carlsbad, CA, USA) medium, so that the sample in the medium is Equation 1 to Equation 7 The final concentrations were 100, 50, and 25 μM.

将检测细胞与磷酸脂多糖LPS(1.5g/mL,Sigma,St.Louis,MO,USA)和重组小鼠干扰素IFN-γ(10ng/mL,PeproTech,Rocky Hill,NJ,USA)同时添加到培养基中。Detection cells were added simultaneously with lipopolysaccharide phosphate LPS (1.5g/mL, Sigma, St. Louis, MO, USA) and recombinant mouse interferon IFN-γ (10ng/mL, PeproTech, Rocky Hill, NJ, USA). in culture medium.

然后,将细胞在37℃下孵育约24小时,随后在冰上冷却。The cells were then incubated at 37°C for approximately 24 hours and subsequently cooled on ice.

随后,将100μL细胞培养上清液平行两份加入96孔板的孔中。为了量化NO,将50μLGriess试剂(1%的磺胺、5%H2PO4溶液和0.1%N-1-萘二甲酰胺二盐酸盐)添加到每个孔中。Subsequently, 100 μL of cell culture supernatant was added into the wells of a 96-well plate in parallel in duplicate. To quantify NO, 50 μL of Griess reagent (1% sulfonamide, 5% H 2 PO 4 solution, and 0.1% N-1-naphthalenedicarboxamide dihydrochloride) was added to each well.

10分钟后,使用酶标仪(BIO-RAD,Hercules,CA,USA)在550nm处对反应产物进行比色定量。使用标准校准曲线计算NO的浓度,不同样品种类和浓度下NO的浓度如图3所示。After 10 minutes, the reaction product was colorimetrically quantified at 550 nm using a microplate reader (BIO-RAD, Hercules, CA, USA). The concentration of NO was calculated using the standard calibration curve. The concentration of NO under different sample types and concentrations is shown in Figure 3.

通过图3可知,式1-式7的化合物均具有抑制一氧化氮(NO)产生的活性。2、3、7在100μM时表现出最强的NO生成抑制活性,抑制率分别为81.8%、46.8%和50.5%,其余化合物在高浓度时表现出弱NO抑制活性。It can be seen from Figure 3 that the compounds of Formula 1 to Formula 7 all have the activity of inhibiting the production of nitric oxide (NO). 2, 3, and 7 showed the strongest NO production inhibitory activity at 100 μM, with inhibition rates of 81.8%, 46.8%, and 50.5% respectively. The remaining compounds showed weak NO inhibitory activity at high concentrations.

显然,上述实施例仅仅是为清楚地说明所作的举例,而并非对实施方式的限定。对于所属领域的普通技术人员来说,在上述说明的基础上还可以做出其它不同形式的变化或变动。这里无需也无法对所有的实施方式予以穷举。而由此所引伸出的显而易见的变化或变动仍处于本发明创造的保护范围之中。Obviously, the above-mentioned embodiments are only examples for clear explanation and are not intended to limit the implementation. For those of ordinary skill in the art, other different forms of changes or modifications can be made based on the above description. An exhaustive list of all implementations is neither necessary nor possible. The obvious changes or modifications derived therefrom are still within the protection scope of the present invention.

Claims (4)

1. An inhibitor of inducible NO-synthase produced by deep sea fungi, characterized by comprising at least one compound of the following formula 1-formula 7,
the deep sea fungi are preserved in China Center for Type Culture Collection (CCTCC) No. M20211395; the preservation time is as follows: 2021, 11/11.
2. A method for preparing an inhibitor of inducible NO synthase, comprising: culturing the deep sea fungus of claim 1 to obtain a culture, and isolating the culture to obtain a product comprising at least one compound of formulae 1-7; the culture process comprises the following steps: after resuscitating the deep sea fungus strain, inoculating the strain into a seed culture medium, and culturing at 27-29 ℃ for 47-49 hours to obtain a seed culture solution; inoculating the seed culture solution into a rice culture medium, and culturing for 40-50 days to obtain a culture;
the seed culture medium comprises the following components in percentage by mass: 1.9-2.1% of glucose, 0.9-1.1% of peptone, 0.4-0.6% of yeast extract, 2-4% of sea salt and the balance of water;
the rice culture medium comprises sea salt, water and rice; the sea salt: water: the mass ratio of the rice is 7-8, 240-260 and 140-160.
3. The preparation method according to claim 2, wherein the preparation method of the rice culture medium comprises the following steps: weighing sea salt according to a proportion, dissolving the sea salt in deionized water, adding rice after the sea salt is completely dissolved, and soaking overnight.
4. A method according to claim 2 or 3, wherein the deep sea fungi are inoculated in the rice culture medium in an amount of: and inoculating 5mL of seed culture solution into every 140-160 g of rice.
CN202111434433.4A 2021-11-29 2021-11-29 Inhibitor of inducible NO synthetase, and production strain and preparation method thereof Active CN114410477B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111434433.4A CN114410477B (en) 2021-11-29 2021-11-29 Inhibitor of inducible NO synthetase, and production strain and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111434433.4A CN114410477B (en) 2021-11-29 2021-11-29 Inhibitor of inducible NO synthetase, and production strain and preparation method thereof

Publications (2)

Publication Number Publication Date
CN114410477A CN114410477A (en) 2022-04-29
CN114410477B true CN114410477B (en) 2023-10-10

Family

ID=81264884

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111434433.4A Active CN114410477B (en) 2021-11-29 2021-11-29 Inhibitor of inducible NO synthetase, and production strain and preparation method thereof

Country Status (1)

Country Link
CN (1) CN114410477B (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102952756A (en) * 2012-08-23 2013-03-06 浙江工业大学 Marine fungi altemaria MNP801 and application thereof
CN103074233A (en) * 2012-12-25 2013-05-01 浙江工业大学 Marine fungus penicillium chrysogenum and application thereof to preparation of anti-tumor medicines
CN104031844A (en) * 2014-05-19 2014-09-10 广东省微生物研究所 Cladosporium sp. strain, and extract and application thereof
CN105503531A (en) * 2015-12-04 2016-04-20 深圳大学 Extract of fungus culture as well as preparation method and application of extract
CN106497797A (en) * 2016-11-01 2017-03-15 深圳大学 A kind of extract of fungal cultures and its preparation method and application
CN108265007A (en) * 2017-12-18 2018-07-10 国家海洋局第三海洋研究所 The application of deep-sea fungi 3A00421 and its fermented cpds
CN108277164A (en) * 2017-12-28 2018-07-13 中山大学 A kind of indene derivative in sea paint endogenetic fungus source and its application in preparing anti-inflammatory drug
CN108795774A (en) * 2017-04-28 2018-11-13 华中科技大学 The separation application of new steroid compound in a kind of Phomopsis and its secondary metabolite
CN111602662A (en) * 2020-06-22 2020-09-01 深圳大学 A kind of preparation method and application of trypsin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3577586B2 (en) * 1998-05-15 2004-10-13 ジェネンテック・インコーポレーテッド IL-17 homologous polypeptides and their therapeutic uses

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102952756A (en) * 2012-08-23 2013-03-06 浙江工业大学 Marine fungi altemaria MNP801 and application thereof
CN103074233A (en) * 2012-12-25 2013-05-01 浙江工业大学 Marine fungus penicillium chrysogenum and application thereof to preparation of anti-tumor medicines
CN104031844A (en) * 2014-05-19 2014-09-10 广东省微生物研究所 Cladosporium sp. strain, and extract and application thereof
CN105503531A (en) * 2015-12-04 2016-04-20 深圳大学 Extract of fungus culture as well as preparation method and application of extract
CN106497797A (en) * 2016-11-01 2017-03-15 深圳大学 A kind of extract of fungal cultures and its preparation method and application
CN108795774A (en) * 2017-04-28 2018-11-13 华中科技大学 The separation application of new steroid compound in a kind of Phomopsis and its secondary metabolite
CN108265007A (en) * 2017-12-18 2018-07-10 国家海洋局第三海洋研究所 The application of deep-sea fungi 3A00421 and its fermented cpds
CN108277164A (en) * 2017-12-28 2018-07-13 中山大学 A kind of indene derivative in sea paint endogenetic fungus source and its application in preparing anti-inflammatory drug
CN111602662A (en) * 2020-06-22 2020-09-01 深圳大学 A kind of preparation method and application of trypsin

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Novel Harziane Diterpenes from Deep-Sea Sediment Fungus Trichoderma sp. SCSIOW21 and Their Potential Anti-Inflammatory Effects;Hongxu Li等;《Marine Drugs》;第19卷(第12期);第1-11页 *
分离自木霉菌Trichoderma sp.的新型化合物Trichoderol A及绝对构型的确定;许兰兰等;《高等学校化学学报》;第37卷(第11期);第1972-1976页 *
翟欣.内生真菌Trichoderma atroviride D16促进丹参酮合成的机制及其栽培应用.2019,(第10期),第D047-6页. *

Also Published As

Publication number Publication date
CN114410477A (en) 2022-04-29

Similar Documents

Publication Publication Date Title
CN107721990B (en) Marine fungus-derived isoindolinone compounds, preparation method thereof and application thereof in preparation of anti-inflammatory drugs
CN106497797B (en) Extract of fungus culture and preparation method and application thereof
CN102911040B (en) Sesquiterpenoids from marine fungi source as well as preparation method and application thereof
CN108277164B (en) A kind of indene derivative derived from sea paint endophytic fungi and its application in the preparation of anti-inflammatory drugs
CN105503531B (en) A kind of extract of fungal cultures and its preparation method and application
CN106518818A (en) Furanone compound and preparation method and application thereof
CN109970538A (en) A class of marine fungi-derived disesquiterpenoids and their preparation method and application in the preparation of anti-inflammatory drugs
CN111253460A (en) A kind of triterpenoid medicine with anti-inflammatory activity and preparation method and application thereof
CN114410477B (en) Inhibitor of inducible NO synthetase, and production strain and preparation method thereof
CN109731051B (en) A kind of Fujian narcissus tea extract and its preparation method and its application in inhibiting periodontitis pathogenic bacteria
CN102659802B (en) Application in terms of the preparation method of coumarin Neolignans and anti-marime fouling thereof
CN101455652B (en) Use of diterpenoids from Isodon japonica var.galaucocalyx in preparing anti-cancer medicine
CN106967024A (en) A kind of α pyrone derivatives and its preparation method and application
CN104311526B (en) Binaphthyl derivatives derived from marine fungi, their preparation methods and their application in anti-tuberculosis
CN112142667A (en) Alkaloid compound and preparation method and application thereof
CN107805188B (en) Biphenyl compound and preparation method and application thereof
CN108707090B (en) A kind of chlorine-containing aromatic compound and its preparation method and use
CN110003153B (en) A kind of benzofuran compound and its preparation method and use
CN104151392A (en) Moebioside A as well as preparation and application thereof
CN110407792A (en) Secalonic acid J derived from Penicillium oxalate and its preparation method
CN110407794B (en) Ryeonic acid K derived from Penicillium oxalicum and its application in inhibiting the proliferation of cancer cells
CN110002996B (en) A kind of diphenyl ether compound and its preparation method and use
CN102584805B (en) Preparation method of one new active ingredient in natural plant
CN111440200A (en) Mixed source terpene alkaloid and anti-Zika virus application thereof
CN114702468B (en) Dihydrobenzofuran compound and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant